Notably, the BRAF protein related to oncogenesis was also dose-dependently downregulated along with its downstream phosphorylated ERK1/2 proteins in BRAF-expressing A375 cells, indicating that FKB plays a critical role against oncogenesis in melanoma cells. This evidence concerns the gene BRAF and melanoma.